October 1 to Be Observed as World Hepatitis-C Awareness Day

[Guest guest]

October 1 to Be Observed as World Hepatitis-C Awareness Day

Source: www.pharmabiz.com

With the objective of educating people about hepatitis C, October 1 will be

observed as the world Hepatitis-C awareness day by the WHO.

In India alone, it is estimated that 1.09 crore people have chronic

hepatitis C. National trends indicate a sizeable concentration of hepatitis

C cases in North Eastern India. Among the metros, 4 lakh Delhiites are

suffering from Hepatitis C and Mumbai accounts for 3 lakh cases. Gujarat

also carries a patient load of 3.37 lakh.

The objective of the World Hepatitis-C awareness day is to draw the

attention of people towards a virus that has emerged as a major global

healthcare problem, infecting approximately three per cent of the world's

population.

Every year the number of people infected with the Hepatitis C virus (HCV)

increases by 30-40 lakh worldwide, adding to the 17 crore people already

infected. The spurt in number is primarily attributed to low awareness about

the disease.

" Today, new therapies have been shown to successfully treat between to 50 to

80 per cent of people infected with Hep C. Currently Roche offers Pegylated

Interferon Alpha 2A (40KD), " said Dr. G. L. Telang, Managing Director, Roche

Scientific Company India Pvt. Ltd.

About Hepatitis C

Hepatitis C is a blood-born viral infection of the liver that was first

identified only in 1989. Few people realise that they are infected as the

symptoms are non-specific (such as fatigue) and people tend to become aware

when their disease is quite advanced. Transmission by blood products has

been reduced to almost zero due to screening for the virus so today the most

common route of transmission is use of unsterilised needles (such as those

used in tattooing and by intravenous drug users) and syringes.

Hepatitis C is the most infectious virus having 50 per cent chronicity and

is responsible for large number of patients affected with cirrhosis. If not

treated early may require liver transplant or may further develop to liver

cancer.

If 100 people became infected with hepatitis C, approximately 25 people

would be able to clear the virus without any medication within six months of

being infected. The majority, however (the other 75 people), would develop

ongoing (called " chronic " ) infection that will require medication to help

get rid of it. Some people will unfortunately not know they are infected and

will develop damage to their liver before the infection is diagnosed.

Untreated, hepatitis C can lead to cirrhosis (scarring of the liver) or

liver cancer and some may require a liver transplant.

[Guest guest]

October 1 to Be Observed as World Hepatitis-C Awareness Day

Source: www.pharmabiz.com

With the objective of educating people about hepatitis C, October 1 will be

observed as the world Hepatitis-C awareness day by the WHO.

In India alone, it is estimated that 1.09 crore people have chronic

hepatitis C. National trends indicate a sizeable concentration of hepatitis

C cases in North Eastern India. Among the metros, 4 lakh Delhiites are

suffering from Hepatitis C and Mumbai accounts for 3 lakh cases. Gujarat

also carries a patient load of 3.37 lakh.

The objective of the World Hepatitis-C awareness day is to draw the

attention of people towards a virus that has emerged as a major global

healthcare problem, infecting approximately three per cent of the world's

population.

Every year the number of people infected with the Hepatitis C virus (HCV)

increases by 30-40 lakh worldwide, adding to the 17 crore people already

infected. The spurt in number is primarily attributed to low awareness about

the disease.

" Today, new therapies have been shown to successfully treat between to 50 to

80 per cent of people infected with Hep C. Currently Roche offers Pegylated

Interferon Alpha 2A (40KD), " said Dr. G. L. Telang, Managing Director, Roche

Scientific Company India Pvt. Ltd.

About Hepatitis C

Hepatitis C is a blood-born viral infection of the liver that was first

identified only in 1989. Few people realise that they are infected as the

symptoms are non-specific (such as fatigue) and people tend to become aware

when their disease is quite advanced. Transmission by blood products has

been reduced to almost zero due to screening for the virus so today the most

common route of transmission is use of unsterilised needles (such as those

used in tattooing and by intravenous drug users) and syringes.

Hepatitis C is the most infectious virus having 50 per cent chronicity and

is responsible for large number of patients affected with cirrhosis. If not

treated early may require liver transplant or may further develop to liver

cancer.

If 100 people became infected with hepatitis C, approximately 25 people

would be able to clear the virus without any medication within six months of

being infected. The majority, however (the other 75 people), would develop

ongoing (called " chronic " ) infection that will require medication to help

get rid of it. Some people will unfortunately not know they are infected and

will develop damage to their liver before the infection is diagnosed.

Untreated, hepatitis C can lead to cirrhosis (scarring of the liver) or

liver cancer and some may require a liver transplant.

[Guest guest]

October 1 to Be Observed as World Hepatitis-C Awareness Day

Source: www.pharmabiz.com

With the objective of educating people about hepatitis C, October 1 will be

observed as the world Hepatitis-C awareness day by the WHO.

In India alone, it is estimated that 1.09 crore people have chronic

hepatitis C. National trends indicate a sizeable concentration of hepatitis

C cases in North Eastern India. Among the metros, 4 lakh Delhiites are

suffering from Hepatitis C and Mumbai accounts for 3 lakh cases. Gujarat

also carries a patient load of 3.37 lakh.

The objective of the World Hepatitis-C awareness day is to draw the

attention of people towards a virus that has emerged as a major global

healthcare problem, infecting approximately three per cent of the world's

population.

Every year the number of people infected with the Hepatitis C virus (HCV)

increases by 30-40 lakh worldwide, adding to the 17 crore people already

infected. The spurt in number is primarily attributed to low awareness about

the disease.

" Today, new therapies have been shown to successfully treat between to 50 to

80 per cent of people infected with Hep C. Currently Roche offers Pegylated

Interferon Alpha 2A (40KD), " said Dr. G. L. Telang, Managing Director, Roche

Scientific Company India Pvt. Ltd.

About Hepatitis C

Hepatitis C is a blood-born viral infection of the liver that was first

identified only in 1989. Few people realise that they are infected as the

symptoms are non-specific (such as fatigue) and people tend to become aware

when their disease is quite advanced. Transmission by blood products has

been reduced to almost zero due to screening for the virus so today the most

common route of transmission is use of unsterilised needles (such as those

used in tattooing and by intravenous drug users) and syringes.

Hepatitis C is the most infectious virus having 50 per cent chronicity and

is responsible for large number of patients affected with cirrhosis. If not

treated early may require liver transplant or may further develop to liver

cancer.

If 100 people became infected with hepatitis C, approximately 25 people

would be able to clear the virus without any medication within six months of

being infected. The majority, however (the other 75 people), would develop

ongoing (called " chronic " ) infection that will require medication to help

get rid of it. Some people will unfortunately not know they are infected and

will develop damage to their liver before the infection is diagnosed.

Untreated, hepatitis C can lead to cirrhosis (scarring of the liver) or

liver cancer and some may require a liver transplant.

[Guest guest]

October 1 to Be Observed as World Hepatitis-C Awareness Day

Source: www.pharmabiz.com

With the objective of educating people about hepatitis C, October 1 will be

observed as the world Hepatitis-C awareness day by the WHO.

In India alone, it is estimated that 1.09 crore people have chronic

hepatitis C. National trends indicate a sizeable concentration of hepatitis

C cases in North Eastern India. Among the metros, 4 lakh Delhiites are

suffering from Hepatitis C and Mumbai accounts for 3 lakh cases. Gujarat

also carries a patient load of 3.37 lakh.

The objective of the World Hepatitis-C awareness day is to draw the

attention of people towards a virus that has emerged as a major global

healthcare problem, infecting approximately three per cent of the world's

population.

Every year the number of people infected with the Hepatitis C virus (HCV)

increases by 30-40 lakh worldwide, adding to the 17 crore people already

infected. The spurt in number is primarily attributed to low awareness about

the disease.

" Today, new therapies have been shown to successfully treat between to 50 to

80 per cent of people infected with Hep C. Currently Roche offers Pegylated

Interferon Alpha 2A (40KD), " said Dr. G. L. Telang, Managing Director, Roche

Scientific Company India Pvt. Ltd.

About Hepatitis C

Hepatitis C is a blood-born viral infection of the liver that was first

identified only in 1989. Few people realise that they are infected as the

symptoms are non-specific (such as fatigue) and people tend to become aware

when their disease is quite advanced. Transmission by blood products has

been reduced to almost zero due to screening for the virus so today the most

common route of transmission is use of unsterilised needles (such as those

used in tattooing and by intravenous drug users) and syringes.

Hepatitis C is the most infectious virus having 50 per cent chronicity and

is responsible for large number of patients affected with cirrhosis. If not

treated early may require liver transplant or may further develop to liver

cancer.

If 100 people became infected with hepatitis C, approximately 25 people

would be able to clear the virus without any medication within six months of

being infected. The majority, however (the other 75 people), would develop

ongoing (called " chronic " ) infection that will require medication to help

get rid of it. Some people will unfortunately not know they are infected and

will develop damage to their liver before the infection is diagnosed.

Untreated, hepatitis C can lead to cirrhosis (scarring of the liver) or

liver cancer and some may require a liver transplant.